Global Artificial Intelligence Eye Screening System 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI05240960

Publication Date:

May 1, 2024

Pages:

113

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Recent advances in machine learning and computer vision have enabled artificial intelligence (AI)-based software trained on millions of retinal photos to screen for disease with high accuracy, often matching or exceeding human performance. The artificial intelligence eye screening system will make screening more convenient, enable large-scale population screening, and reduce screening costs.
The global Artificial Intelligence Eye Screening System market size is projected to grow from US$ 237 million in 2024 to US$ 9713 million in 2030; it is expected to grow at a CAGR of 85.6% from 2024 to 2030.
The 鈥淎rtificial Intelligence Eye Screening System Industry Forecast鈥� looks at past sales and reviews total world Artificial Intelligence Eye Screening System sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Eye Screening System sales for 2023 through 2029. With Artificial Intelligence Eye Screening System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Eye Screening System industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Eye Screening System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Eye Screening System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Artificial Intelligence Eye Screening System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Eye Screening System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Eye Screening System.
The key players of Artificial Intelligence Eye Screening System include Airdoc Technology, Digital Diagnostics and Eyenuk, etc. The top three players hold a share over 55%. Asia-Pacific is the largest market, has a share about 48%. In terms of product type, Diabetic Retinopathy (DR) is the largest segment, occupied for a share of about 53%, and for application ,it apply to Medical Institutions, which has a share about 62%.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Eye Screening System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Diabetic Retinopathy
Age-Related Macular Degeneration (AMD)
Myopia
Others
Segmentation by Application:
Medical Institutions
Great Health Scene
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Diabetic Retinopathy
Age-Related Macular Degeneration (AMD)
Myopia
Others
Segmentation by Application:
Medical Institutions
Great Health Scene
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Artificial Intelligence Eye Screening System 麻豆原创 Size 2019-2030
2.1.2 Artificial Intelligence Eye Screening System 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Artificial Intelligence Eye Screening System by Country/Region, 2019, 2023 & 2030
2.2 Artificial Intelligence Eye Screening System Segment by Type
2.2.1 Diabetic Retinopathy
2.2.2 Age-Related Macular Degeneration (AMD)
2.2.3 Myopia
2.2.4 Others
2.3 Artificial Intelligence Eye Screening System 麻豆原创 Size by Type
2.3.1 Artificial Intelligence Eye Screening System 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence Eye Screening System 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Artificial Intelligence Eye Screening System Segment by Application
2.4.1 Medical Institutions
2.4.2 Great Health Scene
2.5 Artificial Intelligence Eye Screening System 麻豆原创 Size by Application
2.5.1 Artificial Intelligence Eye Screening System 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence Eye Screening System 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Artificial Intelligence Eye Screening System 麻豆原创 Size by Player
3.1 Artificial Intelligence Eye Screening System 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Artificial Intelligence Eye Screening System Revenue by Player (2019-2024)
3.1.2 Global Artificial Intelligence Eye Screening System Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Artificial Intelligence Eye Screening System Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence Eye Screening System by Region
4.1 Artificial Intelligence Eye Screening System 麻豆原创 Size by Region (2019-2024)
4.2 Global Artificial Intelligence Eye Screening System Annual Revenue by Country/Region (2019-2024)
4.3 Americas Artificial Intelligence Eye Screening System 麻豆原创 Size Growth (2019-2024)
4.4 APAC Artificial Intelligence Eye Screening System 麻豆原创 Size Growth (2019-2024)
4.5 Europe Artificial Intelligence Eye Screening System 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Artificial Intelligence Eye Screening System 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Artificial Intelligence Eye Screening System 麻豆原创 Size by Country (2019-2024)
5.2 Americas Artificial Intelligence Eye Screening System 麻豆原创 Size by Type (2019-2024)
5.3 Americas Artificial Intelligence Eye Screening System 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Eye Screening System 麻豆原创 Size by Region (2019-2024)
6.2 APAC Artificial Intelligence Eye Screening System 麻豆原创 Size by Type (2019-2024)
6.3 APAC Artificial Intelligence Eye Screening System 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence Eye Screening System 麻豆原创 Size by Country (2019-2024)
7.2 Europe Artificial Intelligence Eye Screening System 麻豆原创 Size by Type (2019-2024)
7.3 Europe Artificial Intelligence Eye Screening System 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence Eye Screening System by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence Eye Screening System 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence Eye Screening System 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence Eye Screening System 麻豆原创 Forecast
10.1 Global Artificial Intelligence Eye Screening System Forecast by Region (2025-2030)
10.1.1 Global Artificial Intelligence Eye Screening System Forecast by Region (2025-2030)
10.1.2 Americas Artificial Intelligence Eye Screening System Forecast
10.1.3 APAC Artificial Intelligence Eye Screening System Forecast
10.1.4 Europe Artificial Intelligence Eye Screening System Forecast
10.1.5 Middle East & Africa Artificial Intelligence Eye Screening System Forecast
10.2 Americas Artificial Intelligence Eye Screening System Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.2.2 Canada 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.2.3 Mexico 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.2.4 Brazil 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.3 APAC Artificial Intelligence Eye Screening System Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence Eye Screening System 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.3.3 Korea 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.3.4 Southeast Asia 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.3.5 India 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.3.6 Australia 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.4 Europe Artificial Intelligence Eye Screening System Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.4.2 France 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.4.3 UK 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.4.4 Italy 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.4.5 Russia 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.5 Middle East & Africa Artificial Intelligence Eye Screening System Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.5.2 South Africa 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.5.3 Israel 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.5.4 Turkey 麻豆原创 Artificial Intelligence Eye Screening System Forecast
10.6 Global Artificial Intelligence Eye Screening System Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence Eye Screening System Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Artificial Intelligence Eye Screening System Forecast
11 Key Players Analysis
11.1 Airdoc Technology
11.1.1 Airdoc Technology Company Information
11.1.2 Airdoc Technology Artificial Intelligence Eye Screening System Product Offered
11.1.3 Airdoc Technology Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Airdoc Technology Main Business Overview
11.1.5 Airdoc Technology Latest Developments
11.2 Digital Diagnostics
11.2.1 Digital Diagnostics Company Information
11.2.2 Digital Diagnostics Artificial Intelligence Eye Screening System Product Offered
11.2.3 Digital Diagnostics Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Digital Diagnostics Main Business Overview
11.2.5 Digital Diagnostics Latest Developments
11.3 Eyenuk
11.3.1 Eyenuk Company Information
11.3.2 Eyenuk Artificial Intelligence Eye Screening System Product Offered
11.3.3 Eyenuk Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Eyenuk Main Business Overview
11.3.5 Eyenuk Latest Developments
11.4 RetinaLyze System
11.4.1 RetinaLyze System Company Information
11.4.2 RetinaLyze System Artificial Intelligence Eye Screening System Product Offered
11.4.3 RetinaLyze System Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 RetinaLyze System Main Business Overview
11.4.5 RetinaLyze System Latest Developments
11.5 Optomed
11.5.1 Optomed Company Information
11.5.2 Optomed Artificial Intelligence Eye Screening System Product Offered
11.5.3 Optomed Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Optomed Main Business Overview
11.5.5 Optomed Latest Developments
11.6 Sibionics Technology
11.6.1 Sibionics Technology Company Information
11.6.2 Sibionics Technology Artificial Intelligence Eye Screening System Product Offered
11.6.3 Sibionics Technology Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Sibionics Technology Main Business Overview
11.6.5 Sibionics Technology Latest Developments
11.7 Aeye Health
11.7.1 Aeye Health Company Information
11.7.2 Aeye Health Artificial Intelligence Eye Screening System Product Offered
11.7.3 Aeye Health Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Aeye Health Main Business Overview
11.7.5 Aeye Health Latest Developments
11.8 VUNO
11.8.1 VUNO Company Information
11.8.2 VUNO Artificial Intelligence Eye Screening System Product Offered
11.8.3 VUNO Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 VUNO Main Business Overview
11.8.5 VUNO Latest Developments
11.9 Medimaging Integrated Solution
11.9.1 Medimaging Integrated Solution Company Information
11.9.2 Medimaging Integrated Solution Artificial Intelligence Eye Screening System Product Offered
11.9.3 Medimaging Integrated Solution Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Medimaging Integrated Solution Main Business Overview
11.9.5 Medimaging Integrated Solution Latest Developments
11.10 EyRIS (SELENA+)
11.10.1 EyRIS (SELENA+) Company Information
11.10.2 EyRIS (SELENA+) Artificial Intelligence Eye Screening System Product Offered
11.10.3 EyRIS (SELENA+) Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 EyRIS (SELENA+) Main Business Overview
11.10.5 EyRIS (SELENA+) Latest Developments
11.11 Vistel
11.11.1 Vistel Company Information
11.11.2 Vistel Artificial Intelligence Eye Screening System Product Offered
11.11.3 Vistel Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Vistel Main Business Overview
11.11.5 Vistel Latest Developments
11.12 RETINA-AI Health
11.12.1 RETINA-AI Health Company Information
11.12.2 RETINA-AI Health Artificial Intelligence Eye Screening System Product Offered
11.12.3 RETINA-AI Health Artificial Intelligence Eye Screening System Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 RETINA-AI Health Main Business Overview
11.12.5 RETINA-AI Health Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.